Providing unmatched treatments that address all forms of bleeding

Cayuga Biotech is a startup company developing novel hemostatic drugs and devices to treat uncontrollable bleeding episodes. We envision our product as a universal agent able to generate clots in all bleeding scenarios while minimizing the risk of side effects.

Trauma and hemorrhage are intertwined conditions that account for the number one cause of death and disability worldwide. We are developing treatments that promote hemostasis for both trauma-related hemorrhage and rare, inherited bleeding disorders.

Live to tell the story.